Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children’s Oncology Group

Radiolabeled metaiodobenzylguanidine (mIBG) is a highly sensitive and specific marker for detecting neuroblastoma. A semiquantitative mIBG score (Curie score [CS]) was assessed for utility as a prognostic indicator for a cohort of patients with highrisk metastatic disease. METHODS: mIBG scans from 2...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Nucl Med
Main Authors: Yanik, Gregory A., Parisi, Marguerite T., Shulkin, Barry L., Naranjo, Arlene, Kreissman, Susan G., London, Wendy B., Villablanca, Judith G., Maris, John M., Park, Julie R., Cohn, Susan L., McGrady, Patrick, Matthay, Katherine K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5503147/
https://ncbi.nlm.nih.gov/pubmed/23440556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.112.112334
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados